Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 10,295 Maze Therapeutics, Inc. shares (Form 4)

Traded Sep 2 to Sep 3, 2026 · Filed Sep 4, 2026

From Sep 2 to Sep 3, 2026, Bernstein Harold (President, R&D & CMO) sold 10,295 Maze Therapeutics, Inc. shares at an average US$26.24 for US$270K, leaving 9,705 shares. Filed Sep 4, 2026 (Form 4).

Sold
10,295 shares
Price
US$26.24 average (US$25.78 to US$27.12)
Value
US$270K
Holding after
9,705 shares
Trading plan
No
Role
President, R&D & CMO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026Common StockSale4,481US$26.3815,519Direct
Sep 2, 2026Common StockSale625US$27.1214,894Direct
Sep 3, 2026Common StockSale5,130US$26.019,764Direct
Sep 3, 2026Common StockSale59US$25.789,705Direct

Source

View original at SEC

Related